Methods for the treatment and prevention of bacterial biofilms

Expert Opinion on Therapeutic Patents

Volumn 15, Issue 8, 2005, Pages 955-965

  Kaplan, Jeffrey B ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Acyl homoserine lactone; Anti adhesive; Antibacterial; Catheter; Coating; Exopolysaccharide; Furanone; Peptide; Quorum sensing; Triclosan; Vaccine

Indexed keywords

2 HEPTYL 3 HYDROXY 4 QUINOLONE; 2 METHYL 2,3,3,4 TETRAHYDROXYTETRAHYDROFURAN; 3 (1' BROMOHEXYL) 5 DIBROMOMETHYLENE 2(5H) FURANONE; 3 OXO(2 AMINOCYCLOHEXANONE); 3 OXO(2 AMINOCYCLOPENTANOL); ANTIBIOTIC AGENT; BENZALKONIUM; CERULENIN; CHLORHEXIDINE; CIPROFLOXACIN; DISPERSIN B; FATTY ACID SYNTHASE INHIBITOR; FURANONE 56; FURANONE C 30; FURANONE DERIVATIVE; GLYCOSIDASE; HAEMOPHILUS INFLUENZAE VACCINE; ISONIAZID; LACTONE DERIVATIVE; LYSOSTAPHIN; MACROGOL; MINOCYCLINE; N (3 OXODODECANOYL)HOMOSERINE LACTONE; N BUTANOYLHOMOSERINE LACTONE; QUINOLONE DERIVATIVE; RIFAMPICIN; STAPHYLOCOCCUS VACCINE; SULFADIAZINE SILVER; TRICLOSAN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BIOFILM; CATHETER; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG STRUCTURE; FATTY ACID SYNTHESIS; HYDROGEL; INFECTION CONTROL; INFECTION RISK; MATERIAL COATING; MOLECULAR MECHANICS; NONHUMAN; REVIEW;

EID: 23844438413     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.15.8.955     Document Type: Review

References (84)

1. CHRISTENSEN GD, SIMPSON WA, BISNO AL, BEACHEY EH: Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect. Immun. (1982) 37:318-326.
2. HALL-STOODLEY L, COSTERTON JW, STOODLEY P: Bacterial biofilms: from the natural environment to infectious diseases. Natl. Rev. Microbiol. (2004) 2:95-108.
3. PARSEK MR, FUQUA C: Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life J. Bacteriol. (2004) 186:4427-4440.
4. DONLAN RM: Biofilms: microbial life on surfaces. Emerg. Infect. Dis. (2002) 8:881-890.
5. PRAKASH B, VEEREGOWDA BM, KRISHNAPPA G: Biofilms: a survival strategy of bacteria. Curr. Sci. (2003) 85:1299-1307.
6. DUNNE WM: Bacterial adhesion: seen any good biofilms lately? Clin. Microbiol. Rev. (2002) 15:155-166.
7. DONLAN RM, COSTERTON JW: Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. (2002) 15:167-193.
8. PARSEK MR, SINGH PK: Bacterial biofilms: an emerging link to disease pathogenesis. Ann. Rev. Microbiol. (2003) 57:677-701.
9. FUX CA, COSTERTON JW, STEWART PS, STOODLEY P: Survival strategies of infectious biofilms. Trends Microbiol. (2005) 13:34-40.
10. STEWART PS: Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. (2002) 292:107-113.
11. SUGA H, SMITH KM: Molecular mechanisms of bacterial quorum sensing as a new drug target. Curr. Opin. Chem. Biol. (2003) 7:586-591.
12. OTTO M: Quorum-sensing control in Staphylococci - a target for antimicrobial drug therapy? Microbiol. Lett. (2004) 241:135-141.
13. WILLIAMS P: Quorum sensing: an emerging target for antibacterial chemotherapy? Expert Opin. Ther. Targets (2002) 6:257-274.
14. MARCH JC, BENTLEY WE: Quorum sensing and bacterial cross-talk in biotechnology. Curr. Opin. Biotechnol. (2004) 15:495-502.
15. ZHANG LH, DONG YH: Quorum sensing and signal interference: diverse implications. Mol. Microbiol. (2004) 53:1563-1571.
16. SUNTHARALINGAM P, CVITKOVITCH DG: Quorum sensing in streptococcal biofilm formation. Trends Microbiol. (2005) 13:3-6.
17. RICE SA, McDOUGALD D, KUMAR N, KJELLEBERG S: The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections. Curr. Opin. Invest. Drugs (2005) 6:178-184.
18. FUQUA C, GREENBERG EP: Listening in on bacteria: acyl-homoserine lactone signalling. Nat. Rev. Mol. Cell Biol. (2002) 3:685-695.
19. PARSEK MR, GREENBERG EP: Sociomicrobiology: the connection between quorum sensing and biofilms. Trends Microbiol. (2005) 13:27-33.
20. SUTHERLAND IW: Biofilm exopolysaccharide: a strong and sticky framework. Microbiol. (2001) 147:3-9.
21. SUTHERLAND IW: The biofilm matrix - an immobilized but dynamic microbial environment. Trends Microbiol. (2001) 9:222-227.
22. BRANDA SS, VIK A, FRIEDMAN L, KOLTER T: Biofilms: the matrix revisited. Trends Microbiol. (2005) 13:20-26.
23. BELOIN C, GHIGO JM: Finding gene-expression patterns in bacterial biofilms. Trends Microbiol. (2005) 13:16-19.
24. LAZAZZERA BA: Lessons from DNA microarray analysis: the gene expression profile of biofilms. Curr. Opin. Microbiol. (2005) 8:222-227.
25. STANLEY NR, LAZAZZERA BA: Environmental signals and regulatory pathways that influence biofilm formation. Mol. Microbiol. (2004) 52:917-924.
26. HALL-STOODLEY L, STOODLEY P: Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. (2005) 13:7-10.
27. STOODLEY P, SAUER K, DAVIES DG, COSTERTON JW: Biofilms as complex differentiated communities. Ann. Rev. Microbiol. (2002) 56:187-209.
28. WEBB JS, GIVSKOV M, KJELLEBERG S: Bacterial biofilms: prokaryotic adventures in multicellularity. Curr. Opin. Microbiol. (2003) 6:578-585.
29. COSTERTON JW: Cystic fibrosis pathogenesis and the role of biofilms in persistent infections. Trends Microbiol. (2001) 9:50-52.
30. HØIBY N, JOHANSEN HK, MOSER C, SONG Z, CIOFU O, KHARAZMI A: Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. (2001) 3:23-35.
31. GOTZ F: Staphylococcus and biofilms. Mol. Microbiol. (2002) 43:1367-1378.
32. O'GARA JP, HUMPHREYS H: Staphylococcus epidermidis biofilms: importance and implications. J. Med. Microbiol. (2001) 50:582-587.
33. VUONG C, OTTO M: Staphylococcus epidermidis infections. Microbes Infect. (2002) 4:481-489.
34. PESCI E, MILBANK JB, PEARSON JP et al.: Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA (1999) 96:11229-11234.
35. RICE SA, KOH KS, QUECK SY, LABBATE M, LAM KW, KJELLEBERG S: Biofilm formation and sloughing in Serratia marcescens are controlled by quorum sensing and nutrient cues. J. Bacteriol. (2005) 187:3477-3485.
36. GENDRON R, GRENIER D, MAHEU-ROBERT LF: The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect. (2000) 2:897-906.
37. TRAUTNER BW, DAROUICHE RO: Catheter-associated infections: pathogenesis affects prevention. Arch. Intern. Med. (2004) 164:842-850.
38. DONELLI G, FRANCOLINI I: Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review. J. Chemother. (2001) 13:595-606.
39. TRAUTNER BW, HULL RA, DAROUICHE RO: Prevention of catheter-associated urinary tract infection. Curr. Opin. Infect. Dis. (2005) 18:37-41.
40. SCHIERHOLZ JM, FLECK C, BEUTH J, PULVERER G: The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J. Antimicrob. Chemother. (2000) 46:45-50.
41. DAROUICHE RO, NETSCHER DT, MANSOURI MD, MEADE R: Activity of antimicrobial-impregnated silicone tissue expanders. Ann. Plast. Surg. (2002) 49:567-571.
42. VEENSTRA DL, SAINT S, SAHA S, LUMLEY T, SULLIVAN SD: Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. J. Am. Med. Assoc. (1999) 281:261-267.
43. PAI MP, PENDLAND SL, DANZIGER LH: Antimicrobial-coated/bonded and - impregnated intravascular catheters. Ann. Pharmacother. (2001) 35:1255-1263.
44. MUNSON EL, HEARD SO, DOERN GV: In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistance. Chest (2004) 126:1628-1635.
45. BEIKO DT, KNUDSEN BE, WATTERSON JD, CADIEUX PA, REID G, DENSTEDT JD: Urinary tract biomaterials. J. Urol. (2004) 171:2438-2444.
46. SMITH KM, BU Y, SUGA H: Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem. Biol. (2003) 10:81-89.
47. GLANSDORP FG, THOMAS GL, LEE JK et al.: Synthesis and stability of small molecule probes for Pseudomonas aeruginosa quorum sensing modulation. Organic Biomol. Chem. (2004) 2:3329-3336.
48. RASMUSSEN TB, BJARNSHOLT T, SKINDERSOE ME et al.: Screen for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J. Bacteriol. (2005) 187:1799-1814.
49. RASMUSSEN TB, SKINDERSOE ME, BJARNSHOLT T et al.: Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiol. (2005) 151:1325-1340.
50. SMITH RS, IGLEWSKI BH: Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target. J. Clin. Invest. (2003) 112:1460-1465.
51. SMITH KM, BU Y, SUGA H: Library screening for synthetic agonists and antagonists of a Pseudomonas aeruginosa autoinducer. Chem. Biol. (2003) 10:563H571.
52. HENTZER M, RIEDEL K, RASMUSSEN TB: Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiol. (2002) 148:87-102.
53. HENTZER M, WU H, ANDERSEN JB et al.: Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. (2003) 22:3803-3815.
54. RASCH M, BUCH C, AUSTIN B et al.: An inhibitor of bacterial quorum sensing reduces mortalities caused by vibriosis in rainbow trout (Oncorhynchus mykiss, Walbaum). Syst. Appl. Microbiol. (2004) 27:350-359.
55. HUME EBH, BAVEJA J, MUIR B et al.: The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials (2004) 25:5023-5030.
56. BAVEJA JK, WILLCOX MDP, HUME EBH, KUMAR N, ODELL R., POOLE-WARREN LA: Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials (2004) 25:5003-5012.
57. MARTINELLI D, GROSSMAN G, SÉQUIN U, BRANDL H, BACHOFEN R: Effects of natural and chemically synthesized furanones on quorum sensing in Chromobacterium violaceum. BMC Microbiol. (2004) 4:25.
58. TAGA ME, BESSLER BL: Chemical communication among bacteria. Proc. Natl. Acad. Sci. USA (2003) 100:14549-14554.
59. MILLER ST, XAVIER KB, CAMPAGNA SR et al.: Salmonella typhimurium recognizes a chemically distinct form of the bacterial quorum-sensing signal AI-2. Molec. Cell (2004) 15:677-687.
60. SINGH V, EVANS GB, LENZ DH et al.: Femtomolar transition state analogue inhibitors of 5′-methylthioadenosine /S-adenosylhomocysteine nucleosidase from Escherichia coli. J. Biol. Chem. (2005) 280:18265-18273.
61. DE KEERSMAECKER SCJ, VARSZEGI C, VAN BOXEL N et al.: Chemical synthesis of (S)-4,5-dihydroxy-2,3-pentanedione, a bacterial signal molecule precursor, and validation of its activity in Salmonella typhimurium. J. Biol. Chem. (2005) 280:19563-19568.
62. LOWREY CA, McKENZIE KM, QI L, MEIJLER MM, JANDA KD: Quorum sensing in Vibrio harveyi: probing the specificity of the LuxP binding site. Bioorg. Med. Chem. Lett. (2005) 15:2395-2398.
63. DELL'ACQUA G, GIACOMETTI A, CIRIONI O et al.: Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J. Infect. Dis. (2004) 190:318-320.
64. BALABAN N, GOV Y, BITTLER A, BOELAERT JR: Prevention of Staphylococcus aureus biofilms on dialysis catheters and adherence to human cells. Kidney Int. (2003) 63:340-345.
65. BALABAN N, GIACOMETTI A, CIRIONI et al.: Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J. Infect. Dis. (2003) 187:625-630.
66. ROCHE DM, BYERS JT, SMITH DS, GLANSDORP FG, SPRING DR. WELCH M: Communications blackout? Do N-homoserine lactone-degrading enzymes have a role in quorum sensing? Microbiol. (2004) 150:2023-2028.
67. HUANG JJ, HAN JI, ZHANG LH, LEADBETTER JR: Utilization of acylhomoserine lactone quorum signals for growth by a soil pseudomonad and Pseudomonas aeruginosa PAO1. Appl. Environ. Microbiol. (2003) 69:5941-5949.
68. PARK SY, KANG HO, JANG HS, LEE JK, KOO BT, YUM DY: Identification of extracellular N-acylhomoserine lactone acylase from a Streptomyces sp. and its application to quorum quenching. Appl. Environ. Microbiol. (2005) 71:2632-2641.
69. LEE SJ, PARK SY, LEE JJ, YUM DY, KOO BT, LEE JK: Genes encoding the N-acyl homoserine lactone-degrading enzyme are widespread in many subspecies of Bacillus thuringiensis. Appl. Environ. Microbiol. (2002) 68:3919-3924.
70. PARK SY, LEE SJ, OH K et al.: AhlD, an N-acylhomoserine lactonase in Arthrobacter sp. and predicted homologues in other bacteria. Microbiol. (2003) 149:1541-1550.
71. LIN YH, XU JL, HU J et al.: Acyl-homoserine lactone acylase from Ralstonia strain XJ12B represents a novel and potent class of quorum-quenching enzymes. Mol. Microbiol. (2003) 47:849H860.
72. RAMSEY DM, WOZNIAK DJ: Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol. Microbiol. (2005) 56:309-322.
73. PIER GB, BOYER D, PRESTON M et al.: Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J. Immunol. (2004) 173:5671-5678.
74. ITOH Y, WANG X, HINNEBUSCH BJ, PRESTON JF, ROMEO T: Depolymerization of β-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J. Bacteriol. (2005) 187:383-387.
75. KAPLAN JB, RAGUNATH C, VELLIYAGOUNDER K, FINE DH, RAMASUBBU N: Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. (2004) 48:2633-2636.
76. WU JA, KUSUMA C, MOND JJ, KOKAI-KUN JF: Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimirrob. Agents Chemother. (2003) 47:3407-3414.
77. WALSH S, SHAH A, MOND J: Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. Antimicrob. Agents Chemother. (2003) 47:554-558.
78. MAIRA-LITRAN T, KROPEC A, GOLDMANN D, PIER GB: Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine (2004) 22:872-879.
79. BURKHART CN, BURKHART CG: Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int. J. Dermatol. (2003) 42:925-927.
80. POST JC, STOODLEY P, HALL-STOODLEY L, EHRLICH GD: The role of biofilms in otolaryngologic infections. Curr. Opin. Otolaryngol. Head Neck Surg. (2004) 12:185-190.
81. SWIDSINSKI A, SCHLIEN P, PERNTHALER A et al.: Bacterial biofilm within diseased pancreatic and biliary tracts. Gut (2005) 54:388-395.
82. FAGERLIND MG, NILSSON P, HARLÉN M, KARLSSON S, RICE SA, KJELLEBERG S: Modeling the effect of acylated homoserine lactone antagonists in Pseudomonas aeruginosa. Biosystems (2005) 80:201-213.
83. DONG YH, ZHANG XF, SOO HML, GREENBERG EP, ZHANG LH: The two component response regulator PprB modulates quorum-sensing signal production and global gene expression in Pseudomonas aeruginosa. Mol. Microbiol. (2005) 56:1287-1301.
84. RODRIGUE A, QUENTIN Y, LAZDUNSKI A, MEJEAN V, FOGLINO M: Two-component systems in Pseudomonas aeruginosa: why so many? Trends Microbiol. (2000) 8:498-504.